🇺🇸 FDA
Patent

US 8722889

Azaindoles useful as inhibitors of JAK and other protein kinases

granted A61KA61K31/437A61K31/444

Quick answer

US patent 8722889 (Azaindoles useful as inhibitors of JAK and other protein kinases) held by Vertex Pharmaceuticals Incorporated expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
52
CPC classes
A61K, A61K31/437, A61K31/444, A61K31/496, A61K31/506